hepatocellular carcinoma

Is telmisartan effective in treating non-alcoholic steatohepatitis?

harminka — Tue, 03 Mar 2009 11:39:21 -0600

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma.

How to differentiate macro-regenerative nodules from hepato-carcinoma?

harminka — Sat, 11 Oct 2008 06:37:53 -0500

BA, the congenital absence or destruction of intra- or extra-hepatic biliary system, affects about 5 - 10/100 000 live births. End stage liver cirrhosis developed in some BA patients later in life.

How to select anti-hepatitis B virus agents for drug-resistance patients?

harminka — Wed, 24 Sep 2008 11:22:17 -0500

HBV infection may lead to acute liver disease, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma. Over 350 million people worldwide are estimated to be infected chronically by HBV and are therefore at risk of liver failure, cirrhosis, or hepatocellular carcinoma.

Effect of Curcuma wenyujin on human HepG2 cancer cell

harminka — Wed, 24 Sep 2008 10:47:44 -0500

Hepatocellular carcinoma (HCC) is the fifth most common cancer with more than 1 million fatalities occurring annually worldwide. Nowadays in China, the essential oil of Curcuma wenyujin (CWO) has been used as injection to cure paediatric disease such as acute upper respiratory infections, viral myocarditis and acute pneumonia.

causal link between a tumor suppressor gene and liver cancer

harminka — Wed, 04 Jun 2008 08:04:36 -0500

Scientists at Cold Spring Harbor Laboratory (CSHL) have taken the search for cancer-causing genes an important step forward. In a newly published paper, they confirm that a gene called DLC1 is a tumor suppressor.

High circulating D-dimers are associated with presence of ascites

harminka — Wed, 30 Apr 2008 15:08:59 -0500

The liver is the production site of most of the proteins which favour and inhibit the process of coagulation and fibrinolysis. Patients with liver cirrhosis may develop serious coagulopathy and a hyperfibrinolytic state, which contributes to the bleeding tendency.

Sunitinib may slow growth and spread of liver cancer

harminka — Tue, 15 Apr 2008 13:22:35 -0500

Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver, researchers report.

Protein TM4SF5 lets tumor cells grow out of control

harminka — Fri, 21 Mar 2008 15:34:44 -0500

A characteristic of tumor cells is that they grow in an uncontrolled manner. One reason for this is that although normal cells stop growing when they contact one another (a process known as contact inhibition), tumor cells do not.

What change have prokineticin 2/Bv8 in human hepatocellular carcinoma?

harminka — Wed, 19 Mar 2008 06:53:57 -0500

Liver hepatocarcinoma is a highly vascularized cancer, and more and more research is focused on the molecules controlling angiogenesis. In 2001, two novel peptides, known as prokineticin 1/EG-VEGF (PK1/EG-VEGF) and prokineticin 2/Bv8 (PK2/Bv8), were identified, as having potent angiogenic activities.

How Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma

harminka — Thu, 17 Jan 2008 13:18:27 -0600

Many hepatocellular carcinoma (HCC) patients in China may be treated with Traditional Chinese medicine (TCM). Some say it works, others doubt its effectiveness. These stated that a research group in China had found TCM can down-regulate the expression of PTEN in HCC, which may suppress tumor cell growth and regulate tumor cell invasion and metastasis.

Gene variation may elevate risk of liver tumor in patients with cirrhosis

harminka — Wed, 02 Jan 2008 02:51:21 -0600

A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma (HCC), a liver tumor that is the third leading cause of cancer death.

Massive necrosis is common in presence of tumor capsule

harminka — Sat, 24 Nov 2007 09:20:54 -0600

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Prognosis of patients with HCC complicating cirrhosis mainly depends on the tumor growth, progression of the underlying liver disease and the effectiveness of antitumoral treatment.